District Of Columbia 2023-2024 Regular Session

District Of Columbia Council Bill B25-0226

Introduced
3/20/23  
Refer
3/21/23  
Introduced
3/20/23  
Report Pass
10/12/23  
Refer
3/21/23  
Engrossed
11/7/23  
Report Pass
10/12/23  
Enrolled
12/8/23  
Engrossed
11/7/23  
Passed
12/21/23  
Enrolled
12/8/23  
Passed
2/23/24  
Passed
12/21/23  

Caption

Access to Emergency Albuterol and Glucagon Amendment Act of 2023 (now known as "Access to Emergency Medications Amendment Act of 2023")

Impact

The bill significantly alters the framework within which public schools operate with regard to student health management. It places a requirement on public schools to have designated staff members certified in the administration of these medications, increasing preparedness for health emergencies involving students. Additionally, schools will be accountable for maintaining an adequate stock of medications and ensuring timely replacement of expired supplies. This is expected to enhance the level of care available to students in emergency situations.

Summary

Bill B25-0226, known as the 'Access to Emergency Medications Amendment Act of 2023', amends the Student Access to Treatment Act of 2007. Its primary aim is to allow public schools to possess and administer undesignated emergency medications, such as albuterol and glucagon, without needing a specific prescription for each student. This legislation mandates that by February 1, 2024, the Department of Health will establish a plan to facilitate this process and ensure that the emergency medications are available in schools when needed.

Sentiment

The sentiment surrounding B25-0226 appears to be generally positive among its proponents who argue that the bill is a vital step toward ensuring student safety and public health. Supporters emphasize that the ability to promptly administer emergency medications can be life-saving and express approval of increased accessibility to essential health treatments within school settings. However, discussions also reflect concerns regarding potential challenges around implementation and the wellbeing of students who may require these medications in critical situations.

Contention

Notable points of contention in the discourse around this bill include the adequacy of training for staff members designated to administer medications and the timely distribution of supplies by the Department of Health. There is a robust dialogue on ensuring that the protocols for medication administration are comprehensive and handle diverse emergency scenarios effectively. School administrators also express a need for clarity on compliance requirements and the support they can expect from health authorities to meet these new legislative demands.

Companion Bills

No companion bills found.

Similar Bills

KY HB75

AN ACT relating to undesignated glucagon.

KY HB174

AN ACT relating to undesignated glucagon.

IL HB3428

SCH CD-OPIOID ANTAGONIST

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

IL HB3613

SCH CD-OXYGEN TANK

KY HB438

AN ACT relating to undesignated glucagon.

MA H556

Relative to undesignated glucagon rescue therapies in schools

MA H671

Relative to undesignated glucagon rescue therapies in schools